Trump’s tariffs could put more pressure on the U.S. to produce generic drugs. Are we ready?

As the incoming Trump administration prepares for a new term in the White House, the president-elect has promised 60% tariffs on goods from China. While the impact would be far-reaching across industries, the drug market, which escaped the reach of tariffs enacted by Trump during his first term, is lined up for a direct hit.